Table 3.
Authors | Country | Design | Treatment Length and Description | Psychological Well-Being/Cognitive Measures | Other Measures | Type of Technology Used | Psychological/ Cognitive Symptoms Managed |
---|---|---|---|---|---|---|---|
Chan et al. (2016) [22] | Australia | Experimental, single-group uncontrolled open trial design with symptom assessment at pre-treatment, immediately post-treatment, and follow-up assessment. n = 22 |
5 lessons with a total duration of 8 weeks (cognitive and behavioral skills for psychological distress management). |
|
|
iCBT using telephone calls and emails. | General psychological distress, depression, anxiety, quality of life, and kidney disease-related loss. |
Jahromi et al. (2016) [56] | Iran | Single-blind randomized clinical trial.
|
|
|
Telephone assistance. | Self-efficacy (positive attitudes, stress, and decision-making). | |
Gross et al. (2017) [55] | United States of America | Experimental, randomized, active-controlled, open-label trial with a follow-up assessment.
|
|
|
Workshop in teleconference format. | Anxiety, depression, fatigue, and health-related quality of life. | |
Maynard et al. (2019) [28] | Brazil | Experimental, randomized controlled trial.
|
|
|
|
VR games. | Quality of life and depressive symptoms. |
Nguyen et al. (2019) [58] | Australia | Experimental, single-blind pragmatic randomized controlled trial with 1:1 allocation into two parallel groups with repeated measures and follow-up assessment.
|
|
|
tSupport. | Self-management behavior, self-efficacy, and health-related quality of life. | |
Chou et al. (2020) [54] | Taiwan | Quasi-experimental study design to analyze pre- and post-test measures.
|
|
|
VR exercise program using Nintendo Wii Fit. | Fatigue (reduction in vigor and motivation, mental ability, distress, loss of control in mood). | |
Jakubowski et al. (2020) [24] | United States of America | Experimental, single-center pilot feasibility study with a follow-up assessment. n = 10 |
One 45–60 min-session per week for 8 weeks. |
|
Online video-conferencing platform (Vidyo). | Fatigue, depression, and quality of life. | |
Li et al. (2020) [57] | Taiwan | Experimental, two-arm randomized controlled trial with a pretest-posttest design.
|
|
|
|
Self-efficacy (problem-solving, partnership), self-management (partnership, compliance, self-care, and problem-solving), quality of life (cognitive function, sexual function, sleep, quality of social interaction). | |
Zhou et al. (2020) [30] | United States of America | Experimental, randomized controlled trial.
|
|
|
TAM Revised |
|
Depressive symptoms |
Dingwall et al. (2021) [45] | Australia | Experimental, three-arm, waitlist, single-blind randomized controlled trial with 2:2:1 allocation ratio and follow-up assessment.
|
|
|
|
Psychological distress, depressive symptoms, and quality of life (self-care, anxiety, and depression). | |
Hernandez et al. (2021) [32] | United States of America | Experimental, single-arm proof-of-concept trial. n = 20 |
25 min program repeated on two separate occasions during consecutive HD treatment sessions (1 month). |
|
Joviality fully immersive VR mindfulness/meditation program. | Discomfort, safety, and acceptability. | |
Donald et al. (2022) [31] | Canada | Explanatory sequential mixed-methods study with a follow-up assessment. n = 33 |
8 weeks access to MKMH website and 30 min. telephone interviews within 1 month. |
|
|
|
Self-efficacy. |
Sarker et al. (2022) [59] | Bangladesh | Experimental, parallel-group randomized controlled trial with a follow-up assessment.
|
|
|
|
Health education over a mobile phone call using mHealth technology. | Quality of life and motivation for a healthy lifestyle. |
Abbreviations: BKDS (Burden Kidney Disease Scale); CDSES (Chronic Disease Self-Efficacy Scale); CES-D (Center for Epidemiologic Studies Depression Scale); CG (Control Group); CKD (Chronic Kidney Disease); CKD-SM (CKD Self-Management modified); DASI (Duke Activity Status Index); DSS (Delayed Stay Strong); EG (Exercise Group); eHEALS (eHealth Literacy Scale); EQ-5D (European Quality of Life); FACIT-F (Functional Assessment of Chronic Illness Therapy Fatigue); GAD-7 (Generalized Anxiety Disorder 7-ItemScale); Hep B (The Hep B Story); iCBT (Internet-delivered Cognitive Behavioral Therapy); IG (Intervention Group); IPQ (IGroup Presence Questionnaire); ISS (Immediate Stay Strong); K10 (Kessler Distress Scale); KDLS (Kidney Disease Loss Scale); KDQoL (Kidney Disease Quality of Life); KDQoL-SF (Kidney Disease and Quality-of-Life Short-Form); KiKN (Kidney Knowledge Questionnaire); KiKS (Kidney Disease Knowledge Survey); MCS (Mental Component Summaries); Min (minutes); MINI (Mini International Neuropsychiatric Interview); MKMH (My Kidneys My Health); NFSHD (Novel Fatigue Scale for Hemodialysis); PCS (Physical Component Summaries); PHQ-9 (Patient Health Questionnaire-9 Item); PSQI (The Pittsburgh Sleep Quality Index); SDS (Sheehan Disability Scale); SECD (Self-Efficacy for Managing Chronic Disease); SF-12v2 (Short Form 12); SF-36 (Short Form 36 Health Survey); SF-36v2 (Short Form 36); SG (Supervised Exercise Group); SS (Stay Strong); SSQ (Simulator Sickness Questionnaire); STAI (State Trait Anxiety Inventory); SUPPH (Strategies Used by Patients to Promote Health); SUS (System Usability Scale); TAM (Technology Acceptance Model); TAU (Treatment as Usual); tMBSR (Telephone-adapted Mindfulness-based Stress Reduction); tSupport (Telephone Support); VR (Virtual Reality); W (Week).